CTMX icon

CytomX Therapeutics
CTMX

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$13
261% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Mitchell Kapoor
75% 1-yr CTMX win rate
16 Mar ‘26 2 months ago
JP Morgan
JP Morgan
Anupam Rama
100% 1-yr CTMX win rate
16 Mar ‘26 2 months ago
Guggenheim
Guggenheim
Michael Schmidt
50% 1-yr CTMX win rate
9 Mar ‘26 2 months ago